Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Benzodiazepine Receptor Agonists
100%
Evidence-based Clinical Practice Guideline
100%
Insomnia
27%
Making Decisions
18%
Grading of Recommendations
18%
Guideline Development
18%
Assessment Development
18%
Assessment Evaluation
18%
Usual Care
9%
Assessment Approach
9%
Sleep Disorders
9%
Primary Insomnia
9%
Quality Assessment
9%
Duration of Use
9%
Conflict of Interest
9%
Methodologists
9%
Comorbidity
9%
Therapeutic Effect
9%
Patient Preference
9%
Evidence-based Guidelines
9%
Geriatrician
9%
Psychiatrists
9%
Family Physicians
9%
Draft Guideline
9%
Mental Health Conditions
9%
Elderly Adults
9%
Evidence Rating
9%
Chronic Insomnia
9%
Evaluation Approach
9%
Patient Resources
9%
Clinical Considerations
9%
Clinical Pharmacologist
9%
Clinical Pharmacist
9%
Clinical Psychologists
9%
Development Approach
9%
Physical Health Conditions
9%
Narrative Synthesis
9%
Systematic Process
9%
Development Review
9%
Evaluation Quality
9%
Review of Reviews
9%
Harm Effects
9%
Anxiety-depressive Disorders
9%
Primary Care Professionals
9%
Frontline Clinicians
9%
Resource Implications
9%
Serious Harm
9%
Development Quality
9%
Preference Implication
9%
Medicine and Dentistry
Benzodiazepine Receptor Stimulating Agent
100%
Clinician
36%
Decision Making
18%
Mental Health
9%
Primary Health Care
9%
Therapy Effect
9%
Sleep Disorder
9%
Systematic Review
9%
Geriatrician
9%
Psychiatrist
9%
Patient Preference
9%
Methodologist
9%
Primary Insomnia
9%
Comorbidity
9%